Silo Pharma, Inc. (SILO) - הכנסות ממכירות החברה

סמל תאגידי ולוגו של Silo Pharma (SILO)

Silo Pharma, Inc. (SILO) independently conducts preclinical molecule testing, limiting its partnerships to scientific alliances with universities. The product sales trend for the company on GURU.Markets reflects revenue dynamics, where 0.00 shows the current volume of this metric. The organization aims to capture market niches by developing therapies for depression and Alzheimer's disease, implementing psychedelic microdosing to restore brain function without hallucinogenic effects.

SILO Silo Pharma: הכנסות החברה בטווח 28.04.2023 - 16.11.2026

פילוחים אנליטיים של חברת Silo Pharma, Inc.

- שווי מניות ותחזית קונצנזוס למחירים:
ניתוח מקיף של החברה:SILO (Silo Pharma, Inc.)
מוצר המיוצר על ידי Silo Pharma Inc.

For the long-term investor, the sustainability of Silo Pharma, Inc. (SILO) is determined by its ability to monetize innovative developments in psychedelic therapy. Analyzing the company's quarterly sales captures the net volume of product realization without time lags, allowing for an assessment of the market response to the commercialization of patent-protected psilocybin patches and confirming the fundamental viability of the business model through the dynamics of actual cash inflows.